Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
5.25    -1.75 (-25.00%)
Bid:
5.00
Ask:
5.50
Spread: 0.50 (10.00%)
Market Cap: £7.87m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Total Voting Rights

29 Sep 2023 07:00

RNS Number : 8365N
Ondo InsurTech PLC
29 September 2023
 

29 September 2023

 

Ondo InsurTech Plc

("Ondo" or "the Company")

 

Total Voting Rights and Shares in issue update

Ondo InsurTech Plc ("Ondo"), the London-listed leader in claims prevention technology for home insurers, is pleased to provide an update on its Share in Issue and Total Voting rights in accordance with the Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1,

 

Since our announcement on 22 September 2023, no further shares have been issued pursuant to warrant exercises under the Company's blocklisting arrangement.

 

This brings the total shares issued for the calendar month of September from the exercise of warrants and options to 495,577.

 

The Company's issued share capital as at 29 September 2023 now comprises 80,922,736 ordinary shares of 5p each. The Company holds no shares in treasury.

 

Each ordinary share carries the right to one vote in relation to all circumstances at general meetings of the Company. The total number of voting rights in the Company is therefore 80,922,736.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries

 

For further information, please visit www.ondoplc.com or contact the following:

Ondo InsurTech Plc

Craig Foster, CEO

+44 (0) 800 783 9866

SI Capital Ltd

(Company Broker)

Nick Emerson

Jon Levinson

+44 (0) 1483 413500

+44 (0) 20 3143 0600

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRZZGZLRNMGFZG
Date   Source Headline
20th Nov 20237:00 amRNSInterim Results
14th Nov 20237:00 amRNSNationwide Partners with Ondo for LeakBot in U.S.
13th Nov 20237:00 amRNSNotice of Results
30th Oct 20237:00 amRNSAppointment of Dowgate Capital
29th Sep 20237:00 amRNSTotal Voting Rights
25th Sep 20235:53 pmRNSResult of AGM
22nd Sep 20237:00 amRNSWarrant, Options Exercise, Total Voting Rights
1st Sep 20239:56 amRNSTotal Voting Rights
15th Aug 20237:30 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSWarrant / Options / Total Voting Rights Update
8th Aug 20237:17 amRNSNew Partnership with PURE Insurance
3rd Aug 20237:00 amRNSNotification of major holdings
2nd Aug 20231:56 pmRNSNotification of Major Holdings
1st Aug 20239:28 amRNSTotal Voting Rights and Shares in issue update
31st Jul 20231:53 pmRNSAnnual Financial Report and AGM Notice
17th Jul 20237:00 amRNSWaterwise makes Ondo an Affiliate Partner
11th Jul 20237:00 amRNSLoan Note restructuring to support rapid growth
10th Jul 20237:00 amRNSNew five-year contract
5th Jul 20231:47 pmRNSBlock listing Application
30th Jun 20237:00 amRNSAccounting Reference Period
29th Jun 20237:00 amRNSNew deal signed for Australia and New Zealand
14th Jun 20237:00 amRNSNew rapid pilot programme with G4S in Denmark
7th Jun 20237:00 amRNSNew contract with premium US insurer
6th Jun 20237:00 amRNSPortsmouth Water LeakBot Pilot Results Announced
22nd May 20237:00 amRNSPortsmouth Water to share LeakBot Pilot results
15th May 20239:44 amRNSHolding(s) in Company
12th May 20239:44 amRNSPlacing, Subscription and Director/PDMR Dealing
20th Apr 20237:00 amRNSOndo and WNS sign go-to-market channel partnership
1st Feb 20237:00 amRNSDirector / PDMR Dealing
30th Jan 20237:00 amRNSLänsförsäkringar commences LeakBot rollout
16th Jan 20237:00 amRNSNew Danish Contract
21st Nov 202211:42 amEQSOndo InsurTech looking at 'absolutely huge opportunity' in the US
21st Nov 20227:00 amRNSInvestor Event
14th Nov 20221:59 pmEQSOndo InsurTech wins LeakBot contract extension with Hiscox
14th Nov 20227:00 amRNSInterim Results for six months ended 31/08/2022
9th Nov 20227:00 amRNSHiscox signs contract renewal for LeakBot in UK
8th Nov 202211:29 amRNSHolding(s) in Company
26th Sep 202210:19 amRNSAppointment of CFO to Board of Directors
26th Sep 20227:00 amRNSChange of Accounting Reference Period
5th Sep 20227:00 amRNSOndo InsurTech Appoints Kevin Withington as CFO
22nd Aug 20223:31 pmRNSResult of Annual General Meeting
18th Aug 202211:13 amRNSPortsmouth Water Sign Deal
12th Aug 20223:41 pmRNSPDMR Shareholding
10th Aug 20227:00 amRNSPDMR Shareholding
4th Aug 20227:00 amRNSOndo InsurTech receives LSE Green Economy Mark
3rd Aug 20227:00 amRNSPDMR Shareholding
1st Aug 20225:07 pmRNSDirector/PDMR Dealing
1st Aug 20227:00 amRNSLeakBot’s new rollout in Denmark
28th Jul 20227:00 amRNSAnnual Report, Financial Statements & AGM Notice
18th Jul 20227:00 amRNSFirst UK mainstream insurer launches LeakBot

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.